FindTrial
Sign In

Comparing the effect of local ultrasonography guided with Anatomical Landmark Based (Blind) injection of Triamcinolone acetonide for management of De Quervainâ??s tenosynovitis,which will give an evidence based direction to choose an effective therapeutic modality.

A Prospective Study to compare the Effect of Ultrasonography guided versus Anatomical Landmark based (Blind) Triamcinolone Acetonide Injection in De Quervainâ??s Tenosynovitis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042901
Enrollment
80
Registered
2022-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: M654- Radial styloid tenosynovitis [de Quervain]

Interventions

Intervention1: ULTRASONOGRAPHY GUIDED TRIAMCINOLONE ACETONIDE INJECTION IN DE QUERVAINâ??S TENOSYNOVITIS: Part will be paint with 10% povidone iodine and draping with sterile sheet and then a S

Sponsors

SMS Medical College Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All clinically diagnosed patients of De Quervainâ??s tenosynovitis in Department of Physical Medicine & Rehabilitation OPD, SMS Medical College, Jaipur. 2. Those have symptoms of De Quervainâ??s tenosynovitis more than 3 months. 3. Age >18 year 4. Those giving signed informed consent for study.

Exclusion criteria

Exclusion criteria: 1. Previous treatment with local Corticosteroids within 6 months. 2. Previous operation for De Quervainâ??s tenosynovitis in the same wrist. 3. Pregnancy 4.Patients with local infection at the site of the procedure 5. Evidence of diseases like rheumatoid arthritis, gout , carcinoma, and diabetes. 6. Previous history of trauma.

Design outcomes

Primary

MeasureTime frame
1. Pain severity by visual analogue scale (VAS) score 2. PRWE (Patient Rated Wrist Evaluation) scale composed of pain (PRWE-P) and functional disability (PRWE-F) scale score Timepoint: at baseline, 4 weeks and 12 weeks—

Secondary

MeasureTime frame
Modified form of the Vancouver scar scale (mVSS) score for skin hypo pigmentationTimepoint: 4,6 WEEKS—

Countries

India

Contacts

Public ContactMUKESH KUMAR YADAV

SAWAI MANSINGH MEDICAL COLLEGE

kdgupta092@yahoo.in9828141092

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026